Literature DB >> 10640579

Determination of threshold energy dose for ultrasound-induced transdermal drug transport.

S Mitragotri1, J Farrell, H Tang, T Terahara, J Kost, R Langer.   

Abstract

Low-frequency (20 kHz) ultrasound has been shown to enhance transdermal transport of drugs, a phenomenon referred to as sonophoresis. In this paper, we report the threshold energy dose for ultrasound-induced transdermal drug transport. The threshold was determined by in vitro measurements of the dependence of sonophoretic enhancement on ultrasound parameters, including intensity, duty cycle, and exposure time. While the enhancement varies linearly with ultrasound intensity and exposure times, it is independent of the duty cycle in the range of parameters studied. The enhancement is also directly proportional to the ultrasound energy density once the threshold value is crossed. For full thickness pig skin, the threshold value is about 222 J/cm(2). The overall dependence of transport enhancement on ultrasound parameters is similar to that of cavitation measured in a model system, pitting of aluminum foil. Specifically, the extent of pitting is proportional to ultrasound intensity and exposure time and is independent of duty cycle. Furthermore, the extent of pitting is also proportional to the ultrasound energy density. The similarity between the parametric dependence of transport enhancement and cavitation is consistent with previous findings that cavitation plays the dominant role in sonophoresis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640579     DOI: 10.1016/s0168-3659(99)00178-9

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  27 in total

1.  Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery.

Authors:  L Le; J Kost; S Mitragotri
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

2.  In situ determination of partition and diffusion coefficients in the lipid bilayers of stratum corneum.

Authors:  S Mitragotri
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

3.  Frequency dependence of sonophoresis.

Authors:  A Tezel; A Sens; J Tuchscherer; S Mitragotri
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

4.  Intracellular drug delivery using low-frequency ultrasound: quantification of molecular uptake and cell viability.

Authors:  K Keyhani; H R Guzmán; A Parsons; T N Lewis; M R Prausnitz
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

5.  An experimental and theoretical analysis of ultrasound-induced permeabilization of cell membranes.

Authors:  Jagannathan Sundaram; Berlyn R Mellein; Samir Mitragotri
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

6.  Assessment of phonophoresis and iontophoresis in the treatment of carpal tunnel syndrome: a randomized controlled trial.

Authors:  Eda Gurcay; Ece Unlu; Ahmet Gurhan Gurcay; Reyhan Tuncay; Aytul Cakci
Journal:  Rheumatol Int       Date:  2010-12-14       Impact factor: 2.631

7.  Sonophoresis-mechanisms and application.

Authors:  Edina Vranić
Journal:  Bosn J Basic Med Sci       Date:  2004-05       Impact factor: 3.363

8.  The role of cavitation in acoustically activated drug delivery.

Authors:  Ghaleb A Husseini; Mario A Diaz de la Rosa; Eric S Richardson; Douglas A Christensen; William G Pitt
Journal:  J Control Release       Date:  2005-10-03       Impact factor: 9.776

9.  An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport.

Authors:  Hua Tang; Chiao Chun Joanne Wang; Daniel Blankschtein; Robert Langer
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

10.  Applicability and safety of dual-frequency ultrasonic treatment for the transdermal delivery of drugs.

Authors:  Carl M Schoellhammer; Sharanya Srinivasan; Ross Barman; Stacy H Mo; Baris E Polat; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2015-02-04       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.